Ellen Rosenquist, MD
Anesthesiology · Cleveland, OHNPI 1346410198
Payments from drug & device makers
Across 35 payments — averaging $258.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$6K
- Nevro Corp.$654
- Globus Medical$605
- Abbott$368
- Saluda Medical Americas, Inc.$358
- Stryker$339
- plus $960 from 8 others
What the payments were for
- Speaking & faculty fees$5,75063%
- Food & beverage$3,31037%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 3 | $5,777 |
| Nevro Corp. | 6 | $654 |
| Globus Medical | 5 | $605 |
| Abbott | 3 | $368 |
| Saluda Medical Americas, Inc. | 3 | $358 |
| Stryker | 3 | $339 |
| Boston Scientific | 3 | $234 |
| Si-bone, Inc. | 2 | $182 |
| Siemens Medical Solutions USA, Inc. | 1 | $112 |
| Relievant Medsystems, Inc. | 1 | $108 |
| Heron Therapeutics, Inc. | 2 | $101 |
| Vertos Medical, Inc. | 1 | $101 |
| SPR Therapeutics, Inc | 1 | $64 |
| Scilex Pharmaceuticals Inc. | 1 | $59 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INTELLIS ADAPTIVESTIM$5,750
- Senza$700
- mild Device Kit$417
- Evoke$351
- Omnia$246
- GENERAL PAIN MANAGEMENT$214
- Proclaim IPG$148
- PROCLAIM$135
- Senza Spinal Cord Stimulation System$124
- ELSA ATP$121
- Cios Fusion$112
- Intracept$108
How this compares
$9,060 in reported general payments places this provider in the 95th percentile of 1,623 anesthesiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 20 | $1,926 |
| Gabapentin | 56 | $995 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 32 | $897 |
| Amitriptyline Hcl | 33 | $523 |
| Tizanidine Hcl | 34 | $502 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 23 | $358 |
| Duloxetine Hcl | 13 | $220 |
| Diclofenac Sodium | 21 | $209 |
| Meloxicam | 15 | $148 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Cleveland
- Daniel SesslerCleveland$2.2M
- Mehmet TuranCleveland$1.2M
- Sabry AyadCleveland$851K
- Andra DuncanCleveland$748K
- Wael SaasouhCleveland$291K
- Kurt RuetzlerCleveland$257K
- Ehab FaragCleveland$226K
- Melinda LawrenceCleveland$217K
- Luis TollincheCleveland$215K
- Edwin AveryCleveland$194K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.